Skip to main content
Top

09-06-2018 | Rheumatoid arthritis | Article

Disease and management beliefs of elderly patients with rheumatoid arthritis and comorbidity: a qualitative study

Journal: Clinical Rheumatology

Authors: Marloes van Onna, Betül Öztürk, Mirian Starmans, Ralph Peeters, Annelies Boonen

Publisher: Springer London

Abstract

To explore in elderly patients with rheumatoid arthritis (RA) and comorbidity (1) in which order and why patients prioritize their morbidities with regard to functioning and health, (2) their beliefs about common (age-related) musculoskeletal complaints, and (3) experiences about the influence of comorbidity on medication treatment of RA. Patients between 50 and 85 years with RA and ≥ 1 comorbidity or lifestyle risk factor were invited for a semi-structured interview. Two readers coded the transcripts of the interviews, by using NVivo11 software. Fifteen patients (14 women; mean age 67 years (range 51–83 years); mean disease duration 14 years (range 1–39 years)) were interviewed. Only 3 (20%) out of 15 patients prioritized RA over their comorbidity; these patients often experienced severe functional limitations. The level of current or (perceived) future disability, risk of dependency, and the perceived lethality of a condition were considered by participants when prioritizing morbidities. Most participants had misconceptions about common age-related musculoskeletal complaints. Consequently, these participants attributed all joint complaints or even all physical complaints to RA, disregarding degenerative joint disease and physiological aging as alternative diagnoses. Half of the participants ever had to change RA medication because of comorbidity. Most of these patients had prioritized the comorbidity, sometimes even over treatment of RA disease activity. Most elderly RA patients with comorbidity prioritize the importance and treatment of comorbidity over RA. Better understanding of patients’ beliefs on RA and comorbidity is essential when managing chronic conditions in elderly patients.
Literature
1.
Van Onna M, Boonen A (2016) The challenging interplay between rheumatoid arthritis, ageing and comorbidities. BMC Musculoskelet Disord 17:184CrossRefPubMedPubMedCentral
2.
Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH, Casado G, Detert J, el-zorkany B, Emery P, Hajjaj-Hassouni N, Harigai M, Luo SF, Kurucz R, Maciel G, Mola EM, Montecucco CM, McInnes I, Radner H, Smolen JS, Song YW, Vonkeman HE, Winthrop K, Kay J (2014) Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis 73:62–68CrossRefPubMed
3.
Kremers HM, Nicola P, Crowson CS, O'Fallon WM, Gabriel SE (2004) Therapeutic strategies in rheumatoid arthritis over a 40-year period. J Rheumatol 31:2366–2373PubMed
4.
Morris RL, Sanders C, Kennedy AP, Rogers A (2011) Shifting priorities in multimorbidity: a longitudinal qualitative study of patient’s prioritization of multiple conditions. Chronic Illn 7:147–161CrossRefPubMed
5.
England BR, Sayles H, Mikuls TR, Johnson DS, Michaud K (2015) Validation of the rheumatic disease comorbidity index. Arthritis Care Res (Hoboken) 67:865–872CrossRef
6.
Fries JF, Spitz PW, Young DY (1982) The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. J Rheumatol 9:789–793PubMed
7.
Pope C, Mays N (2006) Qualitative research in health care. Blackwell Publishing
8.
Buitinga L, Braakman-Jansen LM, Taal E, van de Laar MA (2012) Worst-case future scenarios of patients with rheumatoid arthritis: a cross-sectional study. Rheumatology (Oxford) 51:2027–2033CrossRef
9.
Schoenberg NE, Leach C, Edwards W (2009) “It’s a toss up between my hearing, my heart, and my hip”: prioritizing and accommodating multiple morbidities by vulnerable older adults. J Health Care Poor Underserved 20:134–151CrossRefPubMedPubMedCentral
10.
Kobue B, Moch S, Watermeyer J (2017) “It’s so hard taking pills when you don’t know what they’re for”: a qualitative study of patients’ medicine taking behaviours and conceptualisation of medicines in the context of rheumatoid arthritis. BMC Health Serv Res 17:303CrossRefPubMedPubMedCentral
11.
Radner H, Yoshida K, Tedeschi S, Studenic P, Frits M, Iannaccone C, Shadick NA, Weinblatt M, Aletaha D, Smolen JS, Solomon DH (2017) Different rating of global rheumatoid arthritis disease activity in rheumatoid arthritis patients with multiple morbidities. Arthritis Rheumatol 69:720–727CrossRefPubMed
12.
Sokka T, Mäkinen H, Hannonen P, Pincus T (2006) Most people over age 50 in the general population do not meet ACR remission criteria or OMERACT minimal disease activity criteria for rheumatoid arthritis. Rheumatology (Oxford) 46:1020–1023CrossRef
13.
Radner H, Smolen JS, Aletaha D (2011) Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritis. Rheumatology (Oxford) 50:381–388CrossRef
14.
Rifkin DE, Laws MB, Rao M, Balakrishnan VS, Sarnak MJ, Wilson IB (2010) Medication adherence behaviour and priorities among older adults with CKD: a semi-structured interview study. Am J Kidney Dis 56:439–446CrossRefPubMedPubMedCentral
15.
Van Tuyl LH, Hewlett S, Sadlonova M et al (2015) The patient perspective on remission in rheumatoid arthritis: ‘You’ve got limits, but you’re back to being you again’. Ann Rheum Dis 74:1004–1010CrossRefPubMed